InvestorsHub Logo
Followers 25
Posts 1509
Boards Moderated 0
Alias Born 01/12/2014

Re: None

Monday, 09/09/2019 4:19:40 PM

Monday, September 09, 2019 4:19:40 PM

Post# of 716104
Interesting find from cognates Aug 7th update - note the sentence about the FDA pre approval inspection preparation

About Cognate BioServices
Cognate is a results-driven contract development and manufacturing organization (CDMO) specializing in cell and cell-mediated gene therapy products. Since 2002, Cognate has serviced autologous and allogeneic products in various stages of development from preclinical to Phase 3, and most recently in pivotal Phase 3 with FDA pre-approval inspection preparation. With development and manufacturing at our core, Cognate made significant investments in infrastructure and quality systems; and we have developed a broad range of commercialization services that facilitate logistics, supply chain planning, and capacity planning to bridge clinical to commercial manufacturing. Cognate provides and develops commercially scalable solutions so that our clients are able to offer safe and high-quality products to as many patients as possible. Please visit www.cognatebioservices.com to find out more about us.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News